Validation of Nafamostat Mesilate as an Anticoagulant in Extracorporeal Membrane Oxygenation: A Large-Animal Experiment

BACKGROUND: Unfractionated heparin is commonly used for anticoagulation in extracorporeal membrane oxygenation (ECMO). Several studies have shown that nafamostat mesilate (NM) has comparable clinical outcomes to unfractionated heparin. This study compared anticoagulation with NM and heparin in a lar...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Korean J Thorac Cardiovasc Surg
Main Authors: Han, Sung Joon, Han, Woosik, Song, Hee-Jung, Kim, Cuk-Seong, Jeong, Seong-Mok, Kang, Min Woong
Formato: Artigo
Idioma:Inglês
Publicado em: The Korean Society for Thoracic and Cardiovascular Surgery 2018
Assuntos:
Clinical Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5894575/
https://ncbi.nlm.nih.gov/pubmed/29662809
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5090/kjtcs.2018.51.2.114
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados